Search

everythinglearnresearchcommunity

for

Search:↓

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

Hair loss, prostate size, and urinary issues are related due to androgen effects.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Celtis choseniana may help treat hair loss by reducing androgen effects and boosting hair growth signals.

Jagged1 and Epidermal Growth Factor together significantly increased hair growth in mice with androgen-suppressed hair.

Hair loss in women, often not related to male hormones, increases with age and can cause significant emotional distress.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

The TRPV3 gene mutation affects hair growth by keeping mice in the growth phase longer, which could help treat hair loss.

Genetics play a role in acne, but how exactly they contribute is not fully understood.

A gene called BMAL1 plays a role in controlling hair growth.

Finasteride 5 mg effectively reduces urinary symptoms and PSA levels in men with enlarged prostates, with few sexual side effects.

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

Correct testosterone levels for age to treat prostate cancer, using low dose treatments as necessary.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

Arteannuin might work against cancer and Alzheimer's by targeting neprilysin.

Lespedeza cuneata extract may help treat enlarged prostate.

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.